Mucoid strains of group A Streptococcus have been associated with recent outbreaks ofacute rheumatic fever. The mucoid colony morphology of these strains is a result of abundant production of capsular polysaccharide, which is composed of hyaluronic acid. To study the role of the hyaluronic acid capsule in virulence, we derived an acapsular mutant from a mucoid strain of group A Streptococcus by transposon mutagenesis. M protein expression was not altered in the mutant strain. The mucoid wild-type strain grew in fresh human blood and was resistant to phagocytic killing in vitro. In contrast, the acapsular mutant failed to grow in fresh human blood and was sensitive to phagocytic killing in vitro. Loss of capsule was associated with a 100-fold reduction in virulence of the organisms in mice. We conclude that the hyaluronic acid capsule protects mucoid group A streptococci from phagocytosis and has an important role in virulence.
Group A Streptococcus (GAS) continues to be a major cause of morbidity and mortality throughout the world, both from infections and from the postinfectious sequelae of acute rheumatic fever and poststreptococcal glomerulonephritis. Recent reports suggest that after declining in frequency in developed countries for the past half-century, the incidence of life-threatening infections due to GAS and of acute rheumatic fever is increasing (1) (2) (3) (4) (5) . The reasons for the resurgence of serious human diseases due to GAS are not known; however, it has been suggested that the GAS strains prevalent today may have increased expression of one or more virulence factors (1, 6) . One such factor may be the hyaluronic acid capsule. Occasional strains of GAS isolated from clinical sources grow as large, spreading, wet colonies on solid media; this characteristic mucoid colony morphology is due to abundant production by these strains of the GAS capsular polysaccharide, which is composed of hyaluronic acid, a high molecular weight polymer consisting of alternating residues of N-acetylglucosamine and glucuronic acid (7, 8) . Mucoid strains of GAS have been implicated as causing unusually severe infections and frequently have been associated with individual cases or community outbreaks of rheumatic fever, including clusters of rheumatic fever cases reported recently from several regions of the U.S.A. (3, 5, 9, 10) . Kaplan et al. (6) studied 42 GAS strains isolated from sibling contacts or patients with acute rheumatic fever during several outbreaks in the mid-1980s and found 45% to be mucoid.
Mucoid isolates are generally rich in M protein and are highly virulent in experimental animals (9, 11) . M protein has been considered to be the major surface component responsible for resistance of GAS to phagocytosis (12) . The fact that highly virulent, M protein-rich strains usually appear mucoid suggests that the presence of a large hyaluronic acid capsule may also confer special virulence properties on these strains. Hirst (13) attempted to define the role of the hyaluronic acid capsule in virulence by experimentally infecting mice with GAS that had been treated with leech extract (containing hyaluronidase); enzymatic decapsulation with hyaluronidase was ineffective in reducing virulence in this model. These studies were criticized by Kass and Seastone (14) , who emphasized the capacity of the organisms to rapidly regenerate capsules in vivo and the presence of serum factors that inactivate hyaluronidase. Kass and Seastone (14) were able to show a substantial improvement in survival of mice challenged with GAS when the animals were treated with repeated doses of hyaluronidase to maintain the infecting organisms in a decapsulated state in vivo. Whitnack et al. (15) found that hyaluronidase treatment of GAS increased adherence of the organisms to peritoneal macrophages but had little effect on the ability of the bacteria to resist phagocytosis in nonimmune human blood.
It is difficult to determine from the varying conclusions of these studies what role the capsule may play in pathogenesis of GAS infection. The apparently discordant results may reflect the fact that wild-type strains studied by different investigators varied in degree of encapsulation or in expression of M protein. In addition, experimental models utilizing bacteria modified by enzyme treatment (13) (14) (15) (16, 17) . GAS strains were grown in Todd-Hewitt broth or on Todd-Hewitt agar containing 5% defibrinated sheep blood. For certain experiments, the culture medium was supplemented with tetracycline (5 pug/ml) and/or streptomycin (500 pug/ml).
Antisera. M protein type 18 GAS antiserum was raised in rabbits by intravenous injection of formalin-fixed organisms of GAS strain 87-282. M protein type 18 GAS reference typing serum (raised in rabbits) was obtained also from R. R. Facklam, Centers for Disease Control.
Isolation of Mutants. Tn916 was transferred from E. faecalis donor strain CG110 to a spontaneous streptomycinresistant mutant of wild-type mucoid GAS strain 87-282, designated 282S1, as described by O'Connor and Cleary (18) . Briefly, cells of donor and recipient strains were mixed in a ratio of 1:1 and deposited on membrane filters. After overnight incubation, bacteria were removed from the filters and plated on medium containing tetracycline and streptomycin. Nonmucoid colonies were serially subcultured three times on tetracycline/streptomycin agar and then frozen at -80°C.
Bacteriophage Transduction. Bacteriophage transduction followed the protocol of Caparon and Scott (19) . Briefly, bacteriophage A25 (provided by June R. Scott, Emory University, Atlanta) was used to infect a broth culture of the nonmucoid transconjugant TD23. A lysate ofthis culture was filtered free of bacterial cells and then transferred to a broth culture of wild-type strain 87-282. Transductants that had incorporated DNA from TD23 containing a Tn916 insertion were selected on tetracycline agar.
Southern Hybridization Analysis. Genomic DNA was isolated from GAS strains as described by O'Connor and Cleary (18) . DNA was digested with restriction endonucleases EcoRI or HindIll, subjected to agarose gel electrophoresis, transferred to a nylon membrane, and probed with 32p-labeled pAM120, previously labeled by nick translation, as described (20, 21) . Tn916 contains no EcoRl sites and a single HindIII site, so each Tn916 insertion was identified by hybridization of the probe to a single EcoRI fragment and to two HindIlI fragments (17) .
Measurement of Cell-Associated Hyaluronic Acid. Bacteria were grown to early logarithmic phase in 150 ml of broth, collected by centrifugation, and washed once with water. Cells were resuspended in 1.5 ml of water and an equal volume of chloroform, mixed vigorously, and allowed to stand at room temperature for 1 hr. After centrifugation, the aqueous phase was assayed for uronic acid content by the carbazole method with testicular hyaluronic acid (Sigma) as a standard (22) .
Preparation of M Protein Extracts. M protein extracts were prepared by acid extraction of bacterial cells as described by Lancefield (23) . That equivalent quantities of bacterial cells of each strain were used for extraction was confirmed by solubilizing duplicate aliquots of the bacterial suspension in 1 M NaOH at 100°C for 5 min and then by determining total cellular protein by the method of Lowry et al. (24) .
In vitro Assays of Phagocytosis. Whole-blood phagocytic assays (the direct bactericidal test of Lancefield) were performed essentially as described (25) . Opsonophagocytic killing in the presence of 10%o (vol/vol) human serum was determined by using a modification of the method of Baltimore et al. (26) . Organisms from a logarithmic-phase broth culture were mixed with leukocytes (6 x 106) isolated from freshly drawn human blood in 0.5 ml of minimal essential medium containing 10%6 human serum previously absorbed with organisms of strain 282S1 to remove specific antibodies.
Aliquots (25 jul) for quantitative culture were withdrawn immediately and after 1 hr of end-over-end rotation at 370C.
Mouse Lethality Studies. Organisms were grown in broth to early logarithmic phase, diluted in fresh broth, and injected i.p. in female CD1 mice weighing =20 g. Serial 1:10 dilutions were administered to groups of six mice. Survivors were counted 3 days after challenge, and LD50 was calculated with data from two such experiments; a total of 60 animals was used for each strain. Survival curves were fit by using the Gompertz model of the PROC PROBIT program, SAS/STAT User's Guide (SAS Institute, Cary, NC).
RESULTS

Derivation of a Nonmucoid Mutant Strain of GAS by Tn916
Mutagenesis. Tn916 is a 16.4-kilobase (kb) transposon that carries a tetracycline-resistance marker and is capable of self-conjugation among a variety of Gram-positive species (16) . Strain 87-282 is a mucoid strain of GAS (M protein type 18) originally isolated from the pharynx of a child with acute rheumatic fever. A spontaneous streptomycin-resistant mutant of strain 87-282, designated 282S1, was used as the recipient in filter mating experiments in which Tn916 was transferred from the high-frequency donor, Enterococcus faecalis CG110. Transconjugants were selected on tetracycline/streptomycin agar and arose at a frequency of 10-4 to 10-5 per recipient cell recovered from the filters at the time of plating on selective media. Approximately 3000 transconjugants were screened by visual inspection for nonmucoid colony morphology. Two nonmucoid transconjugant strains were identified, designated TD23 and TD27.
Genomic DNA was isolated from selected mucoid and nonmucoid transconjugants and examined by Southern hybridization analysis. Most transconjugants were found to contain two or more Tn916 insertions; the nonmucoid strains TD23 and TD27 had three and two transposon insertions, respectively. The nonmucoid transconjugant strain TD23 was selected for further study.
Transduction of the Tn916 Mutation to Wild-Type GAS Strain 87-282. To determine which transposon insertion(s) was responsible for loss ofthe mucoid phenotype, we utilized bacteriophage transduction to transfer the transposon mutation from strain TD23 to the wild-type strain 87-282. We confirmed, by their sensitivity to streptomycin, that all transductants had arisen from wild-type strain 87-282. Of 14 tetracycline resistant transductants screened, 4 grew as nonmucoid colonies. Two nonmucoid transductants, TX4 and TX12, and one mucoid transductant, TX15, were examined by Southern hybridization analysis, which demonstrated a single Tn916 insertion in the nonmucoid transductant TX4, an identical insertion in TX12, and a single insertion at a different chromosomal site in the mucoid transductant TX15 (Fig. 1) . In all transductants examined, the site of transposon insertion corresponded to one of the Tn916 insertion sites in TD23, indicating in all cases incorporation of the Tn916-containing chromosomal fragment of TD23 into the chromosome of the recipient cell by homologous recombination. These findings are consistent with those of Caparon and Scott (27) (30) . Parent strain 282S1 increased in number during incubation in fresh human blood, whereas the nonmucoid transductant TX4 showed no change or a slight decrease in cfu (Table 2) . Strain TX4 grew readily in fresh plasma from which the blood cells had been removed, increasing from 115 cfu to >1000 cfu after 3 hr, confirming that the results in whole blood reflected increased sensitivity of the acapsular mutant to phagocytosis rather than inability to grow in human plasma. As a control for nonspecific effects of Tn9O6 insertion, we also tested the mucoid transductant TX15, which gave results identical to those with 282S1.
Because the usual site of initial colonization and infection with GAS is the pharyngeal mucosa, we also tested the susceptibility ofthe mutant strains to phagocytic killing under conditions more closely resembling those in a pharyngeal exudate. For these assays, the organisms were incubated with human peripheral blood leukocytes in the presence of 10%o human serum. To exclude the possibility that killing of TX4 was due to' small amounts of specific antibody insufficient to opsonize the wild-type strain, the serum used in the assay as a complement source was preabsorbed with organisms of strain 282S1 to remove specific antibodies. Under these conditions the nonmucoid transductant TX4 was readily killed (77-93% decrease in cfu in 1 hr), while the number of organisms of parent strain 282S1 and the mucoid transductant TX15 remained the same or increased (Table 3) . No killing was observed when serum heated at 56'C for 30 min was substituted for normal human serum, indicating that phagocytic killing was complement-dependent.
Loss of Capsule Expression Is Associated with Loss of Virulence in Mice. The principal mode of clearance of GAS from an infected host is phagocytic killing by fixed and circulating phagocytes. We anticipated, therefore, that loss of resistance to phagocytosis in vitro would be reflected in reduced virulence of the acapsular mutant TX4 in vivo. To determine whether the mucoid capsule was important for virulence in vivo, we determined the LD50 in mice for the acapsular mutant TX4, for the parent strain 282S1, and, as a control, for the mucoid transductant TX15. The LD50 values for the parent strain 282S1 and for the mucoid transductant TX15 were similar, 1.3 x 105 cfu and 2.6 x 105 cfu, respectively, while that for the nonmucoid transductant TX4 was 2.0 x 107 cfu (Table 1) . Thus, loss of capsule expression in (31) . The existence of a virulence regulon in GAS has been proposed by Simpson et The association of mucoid strains of GAS with cases of acute rheumatic fever suggests that the presence of a mucoid capsular layer not only confers a capacity for invasive infection, but also alters the immune response of the host to the GAS organism. The pathogenesis of rheumatic fever remains poorly understood, but is thought to involve stimulation by streptococcal antigens of antibodies cross-reactive with host tissues. Hyaluronic acid itself is poorly immunogenic, presumably because of its structural identity with the ground substance of mammalian cartilage (7, 33) . However, the presence of a capsular layer of hyaluronic acid may alter the antibody response to M protein or to other streptococcal products. Alternatively, the relationship between mucoid strains of GAS and rheumatic fever may reflect the capacity of such strains to persist in the host, by virtue of the antiphagocytic effect of the capsule. Prolonged pharyngeal colonization could provide a sufficient antigenic stimulus for production of potentially rheumatogenic antibodies directed against other streptococcal antigens. Our demonstration of the antiphagocytic function of the hyaluronic acid capsule provides a logical basis for the association between mucoid strains of GAS and acute rheumatic fever.
